Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection
Authors
Keywords
-
Journal
mBio
Volume 10, Issue 3, Pages -
Publisher
American Society for Microbiology
Online
2019-05-25
DOI
10.1128/mbio.00597-19
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- From bench to almost bedside: the long road to a licensed Ebola virus vaccine
- (2017) Gary Wong et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Transcriptome Analysis of Circulating Immune Cell Subsets Highlight the Role of Monocytes in Zaire Ebola Virus Makona Pathogenesis
- (2017) Andrea R. Menicucci et al. Frontiers in Immunology
- Transcriptomic analysis reveals a previously unknown role for CD8+ T-cells in rVSV-EBOV mediated protection
- (2017) Andrea R. Menicucci et al. Scientific Reports
- Infection with the Makona variant results in a delayed and distinct host immune response compared to previous Ebola virus variants
- (2017) Krista Versteeg et al. Scientific Reports
- ImmQuant: a user-friendly tool for inferring immune cell-type composition from gene-expression data
- (2016) Amit Frishberg et al. BIOINFORMATICS
- systemPipeR: NGS workflow and report generation environment
- (2016) Tyler W. H. Backman et al. BMC BIOINFORMATICS
- In vivo Ebola virus infection leads to a strong innate response in circulating immune cells
- (2016) Ignacio S. Caballero et al. BMC GENOMICS
- Efficacy of Vesicular Stomatitis Virus–Ebola Virus Postexposure Treatment in Rhesus Macaques Infected With Ebola Virus Makona
- (2016) Andrea Marzi et al. JOURNAL OF INFECTIOUS DISEASES
- Ebola vaccines in clinical trial: The promising candidates
- (2016) Yuxiao Wang et al. Human Vaccines & Immunotherapeutics
- Emergency Postexposure Vaccination With Vesicular Stomatitis Virus–Vectored Ebola Vaccine After Needlestick
- (2015) Lilin Lai et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial
- (2015) Ana Maria Henao-Restrepo et al. LANCET
- VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain
- (2015) A. Marzi et al. SCIENCE
- Next maSigPro: updating maSigPro bioconductor package for RNA-seq time series
- (2014) M. J. Nueda et al. BIOINFORMATICS
- Transcriptional Correlates of Disease Outcome in Anticoagulant-Treated Non-Human Primates Infected with Ebolavirus
- (2014) Sara Garamszegi et al. PLoS Neglected Tropical Diseases
- Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates
- (2013) A. Marzi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IL-27 Promotes IL-10 Production by Effector Th1 CD4+ T Cells: A Critical Mechanism for Protection from Severe Immunopathology during Malaria Infection
- (2011) A. P. Freitas do Rosario et al. JOURNAL OF IMMUNOLOGY
- Management of Accidental Exposure to Ebola Virus in the Biosafety Level 4 Laboratory, Hamburg, Germany
- (2011) Stephan Günther et al. JOURNAL OF INFECTIOUS DISEASES
- The Immunological Genome Project: networks of gene expression in immune cells
- (2008) Tracy S P Heng et al. NATURE IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started